Serum Institute says claims surrounding COVISHIELD’s availability in 73 days are false

By Administrator_India

Capital Sands

Serum Institue of India  issued a statement on August 23, clarifying that all claims surrounding the availability of its COVID-19 vaccine, COVISHIELD, in 73 days are false.

“Presently, the government has granted us permission to only manufacture the vaccine and stockpile it for future use,” SII said in a statement they posted on Facebook, adding that COVISHIELD will be commercialised only after¬†trials are proven successful and after all the requisite regulatory approvals are in place.

SII also touched on the Oxford-AstraZeneca vaccine. “The phase-3 trials for the Oxford-AstraZeneca vaccine are still underway. And only once the vaccine is proven immunogenic and efficacious, SII will confirm its availability, officially,” the company said.

Leave a Reply

Your email address will not be published. Required fields are marked *